Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05333861
What this trial is testing

An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA

Who this might be right for
Primary Immune ThrombocytopeniaAplastic Anemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,150
Not applicableLooking for participantsNCT06107582
What this trial is testing

Longitudinal Cohort of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 500
Testing effectiveness (Phase 2)UnknownNCT06176911
What this trial is testing

The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 124
Not applicableNot Yet RecruitingNCT07070193
What this trial is testing

Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke

Who this might be right for
Immune Thrombocytopenia (ITP)Acute Ischemic Stroke
Peking University People's Hospital 500
Very early researchUnknownNCT06417398
What this trial is testing

Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT02718716
What this trial is testing

Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia
UCB Biopharma SRL 66
Testing effectiveness (Phase 2)Study completedNCT01652599
What this trial is testing

Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT

Who this might be right for
Immune Thrombocytopenic Purpura
Hospital Universitario Dr. Jose E. Gonzalez 30
Testing effectiveness (Phase 2)Looking for participantsNCT07095127
What this trial is testing

Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Nuvig Therapeutics, Inc. 30
Not applicableNot Yet RecruitingNCT07476846
What this trial is testing

RhTPO Dose Escalation vs Eltrombopag Switch in ITP

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 112
Testing effectiveness (Phase 2)WithdrawnNCT01440361
What this trial is testing

Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline
Post-approval studies (Phase 4)UnknownNCT03998982
What this trial is testing

Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 30
Post-approval studies (Phase 4)Looking for participantsNCT07788456
What this trial is testing

Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 38
Testing effectiveness (Phase 2)Looking for participantsNCT07294365
What this trial is testing

DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

Who this might be right for
Immune Thrombocytopenia (ITP)
Dizal Pharmaceuticals 60
Testing effectiveness (Phase 2)UnknownNCT04368598
What this trial is testing

The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 44
Not applicableWithdrawnNCT01869049
What this trial is testing

The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University
Testing effectiveness (Phase 2)UnknownNCT05459649
What this trial is testing

Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 253
Not applicableStudy completedNCT04350164
What this trial is testing

Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.

Who this might be right for
Wiskott-Aldrich Syndrome
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 67
Not applicableNo Longer AvailableNCT03363334
What this trial is testing

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals
Large-scale testing (Phase 3)Active Not RecruitingNCT04562766
What this trial is testing

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Principia Biopharma, a Sanofi Company 232
Not applicableNot Yet RecruitingNCT07212322
What this trial is testing

CD19 UCAR-T Cells in Subjects With Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopahic Inflammatory MyopathiesAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis+4 more
Institute of Hematology & Blood Diseases Hospital, China 24
Next Page